$281 Million is the total value of Bronte Capital Management Pty Ltd.'s 11 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 9.1% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKB | Buy | BERKSHIRE HATHAWAY INC DELcl b new | $72,533,000 | +22.2% | 348,683 | +25.2% | 20.06% | -5.2% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $55,931,000 | +22.0% | 1,477,317 | +37.8% | 15.47% | -5.3% |
| V | Buy | VISA INC | $54,694,000 | +17.3% | 317,972 | +18.4% | 15.12% | -9.0% |
| GOOGL | Buy | ALPHABET INCcap stk cl a | $44,949,000 | +39.3% | 36,809 | +23.5% | 12.43% | +8.1% |
| IBKR | Buy | INTERACTIVE BROKERS GROUP | $38,523,000 | +36.4% | 716,305 | +37.4% | 10.65% | +5.8% |
| CTVA | New | CORTEVA NC | $22,417,000 | – | 800,603 | +100.0% | 6.20% | – |
| GE | Buy | GENERAL ELECTRIC CO | $21,036,000 | +10.3% | 2,352,994 | +29.5% | 5.82% | -14.4% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $18,890,000 | +35.6% | 15,496 | +20.3% | 5.22% | +5.2% |
| TSLA | TESLA INCput | $14,549,000 | +7.8% | 60,400 | 0.0% | 4.02% | -16.4% | |
| SPY | Buy | SPDR S&P 500 ETF TRcall | $10,684,000 | +160.5% | 360,000 | +2471.4% | 2.95% | +102.1% |
| WRLD | Sell | WORLD ACCEP CORP DEL | $7,027,000 | -59.4% | 55,108 | -47.7% | 1.94% | -68.5% |
| IIVI | Buy | II VI INC | $417,000 | +20.2% | 11,833 | +24.6% | 0.12% | -7.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.